Christina To

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Ankylosing Spondylitis

Positron Emission Tomography

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Blood cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Frederick L Locke, Olalekan O Oluwole, John G Kuruvilla, Catherine Thieblemont, Judith Trotman, Gilles Andre Salles, Steven P Rowe, Saran Vardhanabhuti, Joshua Winters, Simone Filosto, Christina To, Paul Cheng, Marco Schupp, Ronald Korn, Marie José Kersten
Axicabtagene ciloleucel vs standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume. Blood 143 (24) (2024)
Frederick L Locke, Olalekan O Oluwole, John G Kuruvilla, Catherine Thieblemont, Judith Trotman, Gilles Andre Salles, Steven P Rowe, Saran Vardhanabhuti, Joshua Winters, Simone Filosto, Christina To, Paul Cheng, Marco Schupp, Ronald Korn, Marie José Kersten
Axicabtagene ciloleucel vs standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume. Blood 143 (24) (2024)
Frederick L Locke, Olalekan O Oluwole, John G Kuruvilla, Catherine Thieblemont, Judith Trotman, Gilles Andre Salles, Steven P Rowe, Saran Vardhanabhuti, Joshua Winters, Simone Filosto, Christina To, Paul Cheng, Marco Schupp, Ronald Korn, Marie José Kersten
Axicabtagene ciloleucel vs standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume. Blood 143 (24) (2024)
Simone Filosto, Saran Vardhanabhuti, Miguel A Canales, Xavier Poire, Lazaros J Lekakis, Sven de Vos, Craig A Portell, Zixing Wang, Christina To, Marco Schupp, Soumya Poddar, Tan Trinh, Carmen M Warren, Ethan G Aguilar, Justin Budka, Paul Cheng, Justin Chou, Adrian Bot, Rhine R Shen, Jason R Westin
Product attributes of CAR T-cell therapy differentially associate with efficacy and toxicity in second-line large B-cell lymphoma (ZUMA-7). Blood cancer discovery (2023)
Michael D Jain, David Bernard Miklos, Caron A Jacobson, John M Timmerman, Jennifer Sun, Jenny Nater, Xiang Fang, Ankit Patel, Madison Davis, Darren Heeke, Tan Trinh, Mike Mattie, Frank Neumann, Jenny J Kim, Christina To, Simone Filosto, Ran Reshef
Axicabtagene Ciloleucel in Combination With the 4-1BB Agonist Utomilumab in Patients With Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results From ZUMA-11. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jason R Westin, Frederick L Locke, Michael J Dickinson, Armin Ghobadi, Mahmoud Elsawy, Tom van Meerten, David Bernard Miklos, Matthew L Ulrickson, Miguel-Ángel Perales, Umar Farooq, Luciano Wannesson, Lori A Leslie, Marie José Kersten, Caron A Jacobson, John M Pagel, Gerald Georg Wulf, Patrick B Johnston, Aaron P Rapoport, Linqiu Du, Saran Vardhanabhuti, Simone Filosto, Jina Shah, Julia Thornton Snider, Paul Cheng, Christina To, Olalekan O Oluwole, Anna Sureda
Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)